LBP Stability Development and Shelf-Life Assessment CRO Service

LBP Stability Development for Shelf-Life Confidence

Live biotherapeutic products are unusually sensitive to temperature, moisture, oxygen exposure, matrix composition, and package configuration. For CMC, formulation, QC, and QA teams, the central question is not only whether viable cell count can be measured today, but whether a target CFU dose, identity, purity, and functional profile can be protected through storage, shipment, and use.

Creative Biolabs provides LBP stability development and shelf-life assessment CRO services that connect stabilization formulation, stability storage, analytical testing, trend interpretation, and documentation into one practical program. Our work helps teams turn strain-specific fragility into controlled evidence for product design, internal CMC gating, partner review, and future dossier planning.

Stabilization

Cryoprotectant, lyoprotectant, and excipient systems for strain-specific viability protection.

Storage Studies

Real-time, accelerated, and stress programs aligned with intended packaging and claims.

CQA Testing

Viable count, moisture, purity, identity, pH, and dosage-form performance readouts.

Shelf-Life Logic

Trend analysis, decay plots, storage recommendations, and initial expiry or retest-period support.

LBP Stability Development and Shelf-Life Assessment Service Details

We provide a strain-specific, dosage-form-aware service pipeline for teams that need to move from promising viable culture to stable product concept, documented stability lot, and defensible shelf-life rationale.

Excipient Formulation Optimization for Stabilization Development

This critical, strain-specific service focuses on maximizing cell viability during the transition to a final drug product, typically a lyophilized, spray-dried, or otherwise dried dosage form. Creative Biolabs evaluates how protectant chemistry, solids content, freezing profile, drying stress, and rehydration behavior affect post-process viable cell count and functional retention.

Cryoprotectant Screening

Evaluation of sugars, polyols, amino acids, proteins, and polymers to protect cells during freezing and drying processes.

Lyoprotectant and Stabilizer Blending

Optimization of stabilizer concentrations and ratios to maximize viable cell count after drying and early storage.

Stability Storage and Testing for Shelf-Life Assessment

We provide comprehensive storage and analytical testing under controlled, continuously monitored conditions. Study designs can connect formulation candidates, container-closure choices, desiccant strategy, label storage conditions, transportation stress, and interval-based QC results.

Real-Time Stability Studies: Testing product samples under recommended storage conditions across the proposed shelf-life duration, such as 12, 24, or 36 months.
Accelerated Stability Studies: Testing samples under elevated temperature and humidity to compare degradation kinetics and quickly estimate shelf-life risk.
Analytical Testing: Routine measurement of potency by viable cell count or CFU, moisture content, purity, identity, pH, and dissolution or release profile when a dosage form requires it.

Sample Submission and Project Requirements

To initiate a stability development project, clients typically provide the following materials and information:

Microbial Strain:

Purified, characterized working cell bank or master cell bank of the LBP.

Process Information:

SOPs or process notes for upstream fermentation and initial downstream purification.

Target Product Profile:

Desired dosage form, required CFU per unit, packaging assumptions, and target shelf life.

Previous Data:

Existing preliminary viability, drying, moisture, formulation, or stability data when available.

Turnaround Time

Interim formulation screening commonly requires 8-12 weeks, depending on strain growth requirements, drying design, analytical method readiness, and the number of excipient matrices. Certificates of Analysis are issued after each planned testing interval for stability lots placed on study.

LBP Stability Development Workflow from Strategy to Shelf-Life Claim

Based on project needs, the workflow moves from strategy validation through optimized formulation, stability-lot generation, and shelf-life reporting.

1

Project Goals

Define target dosage form, intended storage claim, CFU requirement, packaging assumptions, and decision gates.

2

Assay Validation

Review enumeration and viability systems so post-stabilization recovery is measured consistently.

3

Optimization

Identify optimal excipient blends and process conditions for maximum post-drying viability.

4

Scale-Up

Manufacture final formulation stability lots using selected excipient, container, and process parameters.

5

Reporting

Determine shelf life and storage claim using interval data, trend plots, and practical recommendations.

Stability Study Deliverables and Documentation for LBP CMC Teams

Creative Biolabs packages stability development results into practical deliverables that help clients compare candidates, justify formulation choices, and plan future product-quality work.

Deliverable	Content	Decision Value
Interim Formulation Report	Initial screening results, optimized excipient formula, post-drying recovery data, and proposed manufacturing parameters.	Supports formulation selection before larger stability commitments.
Certificate of Analysis	Batch-specific QC data for each stability lot, including planned interval testing results.	Documents lot quality and interval-by-interval status.
Comprehensive Final Report	Stability protocols, raw-data summaries, statistical trend analysis, decay plots, predicted shelf life, and storage recommendations.	Creates a defensible basis for shelf-life and retest-period planning.
Generated Materials	Optimized excipient blends and final formulation material generated during small-scale runs when applicable.	Enables follow-on testing, packaging comparison, and scale-up discussion.

Published Data Supporting LBP Shelf-Life Assessment

CFU stability trends across storage temperatures. (OA Literature) — Fig.1 Plate count stability trends of PDS-08 over time (months) at 5, 25, 30 and 40°C. ^1,2

Recent research on a multi-strain synbiotic showed that storage temperature can sharply change CFU trends, while complementary viability and functional readouts may reveal stability behavior that plate count alone can miss. The image illustrates how refrigerated, room-temperature, elevated-humidity, and accelerated conditions generate different decay patterns, making it easier to compare whether a candidate formulation can maintain the intended viable dose over the proposed storage period and whether accelerated stress signals are consistent with long-term observations.

This matters for LBP development because viable dose, moisture control, packaging, enumeration method performance, and functional retention must be evaluated together before a storage claim is credible. Creative Biolabs supports this need through integrated stability protocols, interval testing, trend analysis, CoA generation, and final documentation that help teams connect formulation choices with practical shelf-life decisions, future CMC planning, packaging selection, and retest-period discussions without treating viability data as an isolated endpoint.

Our Advantages for LBP Stability Development and Shelf-Life Studies

✓

LBP Specialization

We focus on microbial therapies and understand the practical challenges of handling anaerobic, aerobic, and microaerophilic living organisms across formulation and storage workflows.

✓

Customized Solutions

Because stability is strain-specific, we design excipient and study strategies around each organism, dosage form, and storage goal rather than applying a fixed formulation template.

✓

Regulatory Readiness

Study protocols, raw data, CoA outputs, and final reports are organized to support quality review, partner due diligence, and future submission planning.

✓

State-of-the-Art Facilities

Dedicated stability storage chambers, monitored conditions, microbiology-ready testing workflows, and backup systems support consistent interval data generation.

Applications of LBP Shelf-Life and Stability Development Services

Stability development is not just a required test. It shapes whether a living product can keep its intended viable dose, survive real distribution conditions, and reach a usable commercial or clinical presentation.

Biotechnology and Pharmaceutical Companies

For teams developing LBPs or microbiome-based drugs, stability work supports formulation selection, CQA control, release planning, and storage-condition justification.

Nutraceutical and Functional Food Developers

For probiotic supplements and functional ingredients, shelf-life assessment helps validate potency maintenance and practical storage requirements.

Academic and Translational Research Groups

For proprietary strains moving toward licensing or spin-off creation, formal stability assessment strengthens product-readiness discussions.

The Necessity of Stability Development

Living organisms are highly susceptible to heat, moisture, oxidation, osmotic stress, and mechanical stress, any of which can accelerate viability loss. Stability development helps ensure that the stated therapeutic dose remains viable throughout the claimed shelf life, defines CQAs and storage conditions, and clarifies whether shipping and distribution requirements are realistic.

Unlike general stability labs, Creative Biolabs does more than run interval samples. We optimize formulation, packaging assumptions, and analytical checkpoints so stability data can guide actual development decisions.

Recommended Services for LBP Formulation, Stability, and Quality Programs

The following Creative Biolabs services complement LBP stability development by linking formulation design, microbial stabilization, stability testing, and QC analytical readiness within the same development logic.

Live Biotherapeutics: End-to-End Formulation Development & Quality Establishment Service Microbial Stabilization Service Stability Test Services for Live Biotherapeutic Products QC Analytical Test Service for Live Biotherapeutic Products

Frequently Asked Questions

Traditional stability focuses heavily on chemical purity and degradation products. LBP stability must protect a living biological system, so viable count, moisture sensitivity, functional retention, purity, identity, and container-closure behavior are evaluated together.

Sample requirements depend on strain growth characteristics, study arms, testing intervals, analytical methods, and dosage format. After reviewing the target product profile and current process, Creative Biolabs provides a project-specific sample plan.

Yes. We support dried formats such as lyophilized powders as well as liquid or semi-solid concepts when biologically appropriate. The development strategy is adjusted to the formulation's main stressors, including water activity, oxygen exposure, osmotic effects, and temperature sensitivity.

Many programs target 12 to 24 months for practical development and distribution, while some mature products pursue longer claims. The realistic goal depends on strain robustness, dosage form, packaging, storage temperature, initial overage strategy, and allowable potency loss.

Other Resources

Creative Biolabs' Live Biotherapeutics - Brochure

Probiotic Strain Products for NGP Research - Brochure

Custom Small-scale Probiotic Production - Brochure

Live Biotherapeutics - Creative Biolabs - Video

References

Visciglia, Annalisa, et al. "Assessment of shelf-life and metabolic viability of a multi-strain synbiotic using standard and innovative enumeration technologies." Frontiers in Microbiology 13 (2022): 989563. https://doi.org/10.3389/fmicb.2022.989563
Distributed under Open Access license CC BY 4.0, without modification.